Ubertazzi Enrique P, Soderini Hector F E, Saavedra Sanchez Adrian J M, Fonseca Guzman Camilo, Paván Lucila I
Department of gynecology - Urogynecology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Department of gynecology - Urogynecology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Eur J Obstet Gynecol Reprod Biol. 2018 Jun;225:90-94. doi: 10.1016/j.ejogrb.2018.03.060. Epub 2018 Apr 14.
The objective of this study was to evaluate the overall outcomes and complication rates of the transvaginal mesh (TVM) placed for the management of pelvic organ prolapse (POP) at 5-years follow up.
Retrospective cohort study in Urogynecology section in a single center in Argentina. Patients with prolapse stage II or higher were included. Seventy-six patients had TVM surgery for POP and 72 (95%) were available for the 5-year follow-up period.
The cure rate using the combined criteria (leading edge ≤0 according to Pelvic Organ Prolapse Quantification System (POP-Q), no bulge symptoms and no new treatment for prolapse) was 79.2% (57/72) (95% CI 68-88%). Only 5.5% (4/72) (95% CI 1.5-13.6) were re-operated for prolapse recurrence. Mesh exposure occurred in 16.6% of cases (n = 12; 95%CI 8.9-27.3). The incidence of de-novo dyspareunia was 13.3% (2/15) (95%CI 1-40) CONCLUSIONS: We observed that TVM is a durable treatment for prolapse and that adverse events were acceptable without severe complications at 5-year follow-up.
本研究的目的是评估经阴道网片（TVM）用于治疗盆腔器官脱垂（POP）5年随访的总体疗效和并发症发生率。
在阿根廷一个中心的妇科泌尿学部门进行的回顾性队列研究。纳入脱垂II期或更高期的患者。76例患者接受了TVM治疗POP手术，72例（95%）可进行5年随访。
采用综合标准（根据盆腔器官脱垂定量系统（POP-Q）前缘≤0、无膨出症状且未进行新的脱垂治疗）的治愈率为79.2%（57/72）（95%CI 68-88%）。仅5.5%（4/72）（95%CI 1.5-13.6）因脱垂复发再次手术。16.6%的病例（n = 12；95%CI 8.9-27.3）出现网片暴露。新发性交困难的发生率为13.3%（2/15）（95%CI 1-40）。结论：我们观察到TVM是一种持久的脱垂治疗方法，在5年随访中不良事件可接受，无严重并发症。
